Serum matrix metalloproteinase-9 is an early marker of pancreatic necrosis in patients with severe acute pancreatitis

Hepato-Gastroenterology

Volumn 59, Issue 117, 2012, Pages 1594-1598

  Guo, Jia ^a   Xue, Ping ^a   Yang, Xiao Nan ^a   Liu, Xu Bao ^a   Huang, Wei ^b   Xia, Qing ^a  

^a SICHUAN UNIVERSITY   (China)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Matrix metalloproteinase 9; Matrix metalloproteinases; Pancreatic necrosis; Severe acute pancreatitis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6;

ACUTE PANCREATITIS; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PANCREAS NECROSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; APACHE; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84865164667     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11563     Document Type: Article

References (25)

1. Fagenholz PJ, Fernandez-del Castillo C, Harris NS, et al.: National study of United States emergency department visits for acute pancreatitis, 1993-2003. BMC Emerg Med 2007; 7:1.
2. Lu F, Huang H, Wang F, et al.: Intestinal capillary endothelial barrier changes in severe acute pancreatitis. Hepato-Gastroenterol 2011; 58(107-108):1009-1017.
3. Martins FP, De Paulo GA, Conceição RD, et al.: Incidence, risk factors and ERCP outcome for biliary complications after cadaveric OLT. Hepato-Gastroenterol 2011; 58(107-108):732-737.
4. Hughes SJ, Papachristou GI, Federle MP, et al.: Necrotizing pancreatitis. Gastroenterol Clin North Am 2007; 36:313-323.
5. Toouli J, Brooke-Smith M, Bassi C, et al.: Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002; 17:S15-39.
6. Wittau M, Scheele J, Gölz I, et al.: Changing role of surgery in necrotizing pancreatitis: a single-center experience. HepatoGastroenterol 2010; 57(102-103):1300-1304.
7. Huang QL, Qian ZX, Li H: A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis. Hepato-Gastroenterol 2010; 57(102-103):1295-1299.
8. Zhu L, Chen G, Xia Q, et al.: Use of band cell percentage as an early predictor of death and ICU admission in severe acute pancreatitis. Hepato-Gastroenterol 2010; 57(104):1543-1548.
9. Mann DV, Hershman MJ, Hittinger R, et al.: Multicentre audit of death from acute pancreatitis. Br J Surg 1994; 81:890-893.
10. Descamps FJ, Martens E, Ballaux F, et al.: In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes. J Pathol 2004; 204:555-561.
11. Keck T, Balcom JH 4th, Fernandez-del Castillo C, et al.: Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat Gastroenterol 2002; 122:188-201.
12. Keck T, Jargon D, Klünsch A, et al.: MMP-9 in serum correlates with the development of pulmonary complications in experimental acute pancreatitis. Pancreatology 2006; 6:316-322.
13. Muhs BE, Patel S, Yee H, et al.: Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis. J Surg Res 2001; 10:21-28.
14. Xue P, Deng LH, Zhang ZD, et al.: Infectious Complications in Patients with Severe Acute Pancreatitis. Digestive Diseases and Sciences 2009; 54(12):2748-2753.
15. Van den Biezenbos AR, Kruyt PM, Bosscha K, et al.: Added value of CT criteria compared to clinical SAP score in patients with acute pancreatitis. Abdom Imaging 1998; 23:622-626.
16. Balthazar EJ, Ranson JHC, Naidich DP, et al.: Acute pancreatitis: Prognostic value of CT. Radiology 1985; 156:767-772.
17. Barauskas G, Svagzdys S, Maleckas A: C-reactive protein in early prediction of pancreatic necrosis. Medicina (Kaunas) 2004; 40:135-140.
18. Xue P, Deng LH, Zhang ZD, et al.: Effect of antibiotic prophylaxis on acute necrotizing pancreatitis: results of a randomized controlled trial. J Gastroenterol Hepatol 2009; 24:736-742.
19. Pitchumoni CS, Patel NM, Shah P: Factors influencing mortality in acute pancreatitis: can we alter them? J Clin Gastroenterol 2005; 39:798-814.
20. AI Mofleh IA: Severe acute pancreatitis: Pathogenetic aspects and prognostic factors. World J Gastroenterol 2008; 14:675-684.
21. Mikami Y, Dobschütz EV, Sommer O, et al.: Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis. Surgery 2009; 145:147-156.
22. Müller-Pillasch F, Gress TM, Yamaguchi H, et al.: The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from ceruleininduced pancreatitis. Pancreas 1997; 15:168-175.
23. Agarwal N, Pitchumoni CS, Sivaprasad AV: Evaluating tests for acute pancreatitis. Am J Gastroenterol 1990; 85:356-366.
24. Yadav D, Agarwal N, Pitchumoni CS: A Critical Evaluation of Laboratory Tests in Acute Pancreatitis. Am J Gastroenterol 2002; 97:1309-1318.
25. Forsmark CE, Baillie J: AGA Institute technical review on acute pancreatitis. Gastroenterol 2007; 132:2022-2044.